genprowebdirectory
GEN Edge
News
Insights
Trends for 2021
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
Coronavirus
Synthetic Data for a Real Pandemic
Gene Therapy
Bayer Approach to Partnerships, Pipelines, and Platforms
Genomics
Genomics in the Clinic: A Candid Conversation with Sema4 CEO Eric…
Circulating Tumor Cell
Illumina Launching Pan-Cancer IVD Test, Cloud-Based Bioinformatics Platform
Biomarkers
Guardant Health Launches Early-Stage Colorectal Cancer ctDNA Assay
News
Cancer
Bioenergetic Mechanism for Signal Regulation May Explain Cancer’s Warburg Effect
Cannabinoids
Cannabidiol’s Antibiotic Potential Extends to Gram-Negative Bacteria
Neuroscience
Dopamine Circuit Responsible for Temporary Memory Loss
OMICs
Skin Cell Atlas Uncovers Origin of Inflammatory Skin Disease
Animal Models
CRISPR-Based Cancer Cell Lineage Tracing Offers Insights into Drivers of Metastasis
Insights
All
Trends for 2021
Trends for 2020
Bioprocessing
Biopharma Manufacturers Shouldn’t Rush When “Going Digital”
Bioprocessing
Separating Cells with Microfluidics
Trends for 2021
Beyond 2021: Cell Therapy Manufacturing Trends
Bioprocessing
Machine Learning for Better Bioprocess Data Analysis
A-Lists
January 2021 Vol. 41 No. 1
Seven Biopharma Trends to Watch in 2021
A-Lists
Top 15 Best-Selling Drugs Launched in 2020
A-Lists
Top 50 NIH-Funded Institutions of 2020
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
June 2020 Vol. 40 No. 6
In Praise of Lesser-Sung Life Sciences Clusters
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Cancer
Bioenergetic Mechanism for Signal Regulation May Explain Cancer’s Warburg Effect
Cannabinoids
Cannabidiol’s Antibiotic Potential Extends to Gram-Negative Bacteria
OMICs
Skin Cell Atlas Uncovers Origin of Inflammatory Skin Disease
Animal Models
CRISPR-Based Cancer Cell Lineage Tracing Offers Insights into Drivers of Metastasis
Magazine
January 2021 Vol. 41 No. 1
Seven Biopharma Trends to Watch in 2021
January 2021 Vol. 41 No. 1
Leroy Hood: Reflections on a Legendary Career
January 2021 Vol. 41 No. 1
COVID-19 One Year Later: The Biology and the Business
Traditional Medicine
Monoclonal Antibodies: Developers Explore New Territories
Roundtable
Uncharted Territory: Top Challenges Facing Gene Therapy Development
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Cancer
Lymphoma
Lymphoma
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Lymphoma
Culprit Behind Immunotherapy Resistance in Some Lymphomas Revealed
Lymphoma
Lymphoma-Associated Metabolic Enzyme May Be a Drug Target
Lymphoma
Gilead to Acquire Forty Seven for $4.9B, Expanding Immuno-Oncology Pipeline
Lymphoma
Engineered Probiotic Bacteria Deliver Anticancer Nanobodies to Regress Tumors in Mice
Lymphoma
Jakafi Success Helps Incyte Land Blockbuster MorphoSys Partnership
Lymphoma
Catalent Agrees to Manufacture BeiGene’s Tyrosine Kinase Inhibitor for Lymphoma Therapy
Lymphoma
Allogene, Notch Partner to Develop iPSC-Derived Blood Cancer Therapies
Lymphoma
Janssen, Genmab Partner on Follow-On to Darzalex for Multiple Myeloma, Diffuse...
Lymphoma
Lymphoma Resistance Mechanism to Chemo Drug Identified
Lymphoma
Cancer Drug Developers GTx, Oncternal Plan Reverse Merger
Lymphoma
FDA Approves First Non-Chemo Combination Therapy for a Form of Leukemia
Lymphoma
Harbour BioMed to Develop Kelun-Biotech’s Cancer Immunotherapy Candidate A167
Lymphoma
Epizyme Halts Phase II Trial of Tazemetostat in DLBCL Cohorts, Continues...
Lymphoma
Aggressive Lymphoma Linked with JAK Inhibitor Use
Lymphoma
FDA Imposes Partial Clinical Hold on Epizyme Lead Candidate after Patient...
Load more
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
